Why the latest charge — that Mylan overcharged government by millions — should really scare its executives By: MarketWatch October 06, 2016 at 07:16 AM EDT Mylan has told the government for 20 years that the EpiPen was a generic drug. Read More >> Related Stocks: Mylan